These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11454569)

  • 1. Fluvastatin inhibits O2- and ICAM-1 levels in a rat model with aortic remodeling induced by pressure overload.
    Katoh M; Kurosawa Y; Tanaka K; Watanabe A; Doi H; Narita H
    Am J Physiol Heart Circ Physiol; 2001 Aug; 281(2):H655-60. PubMed ID: 11454569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide mediates the effect of fluvastatin on intercellular adhesion molecule-1 and platelet endothelial cell adhesion molecule-1 expression on human endothelial cells.
    Xenos ES; Stevens SL; Freeman MB; Cassada DC; Goldman MH
    Ann Vasc Surg; 2005 May; 19(3):386-92. PubMed ID: 15818460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver.
    Kocarek TA; Reddy AB
    Drug Metab Dispos; 1996 Nov; 24(11):1197-204. PubMed ID: 8937853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
    Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M
    Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.
    Mitani H; Bandoh T; Ishikawa J; Kimura M; Totsuka T; Hayashi S
    Br J Pharmacol; 1996 Nov; 119(6):1269-75. PubMed ID: 8937733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits.
    Rikitake Y; Kawashima S; Takeshita S; Yamashita T; Azumi H; Yasuhara M; Nishi H; Inoue N; Yokoyama M
    Atherosclerosis; 2001 Jan; 154(1):87-96. PubMed ID: 11137086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes.
    Yamamoto A; Hoshi K; Ichihara K
    Eur J Pharmacol; 1998 Nov; 361(1):143-9. PubMed ID: 9851551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of fluvastatin on cICAM-1 as a biomarker of endothelial dysfunction in patients with dyslipidemia.
    Sejda T; Jedlièková V; Svandová E; Poledne R
    Int Angiol; 2006 Dec; 25(4):414-7. PubMed ID: 17164750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on nitric oxide-induced hydroxyl radical generation in the rat heart.
    Obata T; Ebihara A; Yamanaka Y
    Biochim Biophys Acta; 2001 Apr; 1536(1):55-63. PubMed ID: 11335104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis.
    Haruna Y; Morita Y; Yada T; Satoh M; Fox DA; Kashihara N
    Arthritis Rheum; 2007 Jun; 56(6):1827-35. PubMed ID: 17530711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes.
    Takahashi HK; Mori S; Iwagaki H; Yoshino T; Tanaka N; Weitz-Schmidt G; Nishibori M
    J Leukoc Biol; 2005 Mar; 77(3):400-7. PubMed ID: 15618295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitor, fluvastatin, has cholesterol-lowering independent "direct" effects on atherosclerotic vessels in high cholesterol diet-fed rabbits.
    Mitani H; Egashira K; Kimura M
    Pharmacol Res; 2003 Nov; 48(5):417-27. PubMed ID: 12967585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide.
    Romano M; Mezzetti A; Marulli C; Ciabattoni G; Febo F; Di Ienno S; Roccaforte S; Vigneri S; Nubile G; Milani M; Davì G
    J Investig Med; 2000 May; 48(3):183-9. PubMed ID: 10822898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line.
    Niwa S; Totsuka T; Hayashi S
    Int J Immunopharmacol; 1996 Nov; 18(11):669-75. PubMed ID: 9089010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production.
    Bouloumié A; Bauersachs J; Linz W; Schölkens BA; Wiemer G; Fleming I; Busse R
    Hypertension; 1997 Oct; 30(4):934-41. PubMed ID: 9336396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early intervention on atherosclerosis by fluvastatin and lectin-like oxidized low-density lipoprotein receptor-1 expression in atherosclerotic arteries in immature rabbits].
    Yu YH; Wang Y; Chen Y; Liu ZZ; Sun SZ; Meng XH
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):762-6. PubMed ID: 16255856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.
    Mascaró C; Ortiz JA; Ramos MM; Haro D; Hegardt FG
    Arch Biochem Biophys; 2000 Feb; 374(2):286-92. PubMed ID: 10666309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules.
    Mueck AO; Seeger H; Wallwiener D
    Exp Clin Endocrinol Diabetes; 2001; 109(3):181-3. PubMed ID: 11409302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.